Suppr超能文献

导管插入术后股动脉假性动脉瘤患者经皮注射凝血酶的并发症

Complications of percutaneous thrombin injection in patients with postcatheterization femoral pseudoaneurysm.

作者信息

Kurzawski Jacek, Sadowski Marcin, Janion-Sadowska Agnieszka

机构信息

Świȩtokrzyskie Cardiology Center, Grunwaldzka 45, 25-736 Kielce, Poland.

出版信息

J Clin Ultrasound. 2016 Mar-Apr;44(3):188-95. doi: 10.1002/jcu.22274. Epub 2015 Jul 14.

Abstract

PURPOSE

To study the complications of ultrasound-guided thrombin injection of pseudo-aneurysms occurring after interventional cardiovascular procedures.

METHOD

We prospectively studied 353 patients who developed post-catheterization femoral artery pseudo-aneurysms and were treated with ultrasound-guided thrombin injection.

RESULTS

Arterial micro-embolization occurred in 53 patients (15%) and pulmonary embolism in 1 patient (0.3%). None of the patients developed significant peripheral arterial embolism. The length of the communicating channel between the arterial lumen and the pseudo-aneurysm was inversely correlated with the risk of embolization (p < 0.0001). A 4.6 mm increase in channel length decreased the odds of embolization by 14%, and patients with a channel less than 2 mm long were at greater risk. Repeated thrombin injection also increased the risk of embolization (p = 0.02).

CONCLUSION

Thrombin injection for the treatment of post-catheterization femoral pseudo-aneurysm is feasible and safe, but it must be performed with caution, especially when the sac is directly communicating with the artery, or when success cannot be achieved with a single injection.

摘要

目的

研究超声引导下注射凝血酶治疗心血管介入术后股动脉假性动脉瘤的并发症。

方法

我们前瞻性地研究了353例导管插入术后发生股动脉假性动脉瘤并接受超声引导下凝血酶注射治疗的患者。

结果

53例患者(15%)发生动脉微栓塞,1例患者(0.3%)发生肺栓塞。无一例患者发生严重的外周动脉栓塞。动脉腔与假性动脉瘤之间的交通通道长度与栓塞风险呈负相关(p<0.0001)。通道长度每增加4.6毫米,栓塞几率降低14%,通道长度小于2毫米的患者风险更高。重复注射凝血酶也会增加栓塞风险(p = 0.02)。

结论

注射凝血酶治疗导管插入术后股动脉假性动脉瘤是可行且安全的,但必须谨慎操作,尤其是当瘤腔与动脉直接相通或单次注射未能成功时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验